17.06.2008

BCS-based biowaiver: Extension to Class-III drugs?

Prof. Dr. Henning Blume, SocraTec R&D GmbH
EUFEPS Conference, Bad Homburg

 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on single presentations